WELCOME

Dear colleagues,

It is thrilling how new diagnostic and therapeutic methods for vascular diseases are showing up almost every week. However, to assess this progress correctly, thorough understanding of the underlying etiology and the interaction between blood flow and the atherosclerotic or aneurysmatic arteries is mandatory. This goal can only be achieved by mutual exchange between vascular clinicians and fundamental/translational researchers. Thereby, the 4th Munich Aortic & Carotid Conference (MAC) aims to connect the frequently diverging worlds of fundamental science, clinical research and clinical practice.

We are very happy to invite you to the 4th MAC on the first December weekend 2014. Again, we will focus on aortic and carotid issues; a joint meeting with topics ranging from basic science and engineering to clinical issues and patient care. In detail, the aortic sessions will include ascending aortic and aortic arch issues, current indications for TEVAR in acute aortic dissections and the management of type II endoleaks after EVAR. Further special sessions will address the current role of simulation techniques in modeling and understanding of vascular disease. Since the technical progress in hybrid ORs is extremely rapid, we will again discuss options on how to optimize the workflow by using imaging fusion techniques and endovascular navigation.

The carotid sessions will feature topics, such as clinical trials, the optimal timing of invasive treatment in carotid-related cerebral ischemia, the assessment of asymptomatic carotid stenoses, and carotid plaque vulnerability.

Many attendees of MAC favor to attend all main carotid and aortic sessions. To overcome the conflict of parallel sessions, Friday, December 5th will be reserved for the main aortic sessions and Saturday, December 6th, for the main carotid sessions respectively. Parallel sessions will only be scheduled for special issues. Again, we are very proud to present a world-class faculty of national and international experts in clinical and translational vascular research. Our speakers are very experienced presenters and all of them are keen to exchange their ideas with the audience. We are fully aware that in-depth discussion following the oral presentation is sometimes even more interesting for the audience than the lecture itself. Therefore, sufficient time is scheduled for extensive discussions with the audience.

For the first time, scientific abstracts were submitted. Out of almost 40 submissions we selected seven abstracts for oral presentation and included them into the scientific program. Further 27 submitters were chosen to present their abstracts as posters. The best presentations will be awarded EUR 500.00! The 4th MAC 2014 is a platform where clinical researchers from vascular/cardiovascular surgery, neurology, cardiology, angiology and anesthesiology can meet radiologists and imaging specialists, vascular biologists and basic researchers in a very friendly and relaxed atmosphere.

Do not miss the opportunity to share the latest insights into the world of academic vascular research, represented by our world-class national and international faculty! The 4th MAC will provide you with late-breaking news and cutting-edge approaches in vascular medicine and will enable you to be part of the thrilling progress of improving the diagnosis and treatment of carotid and aortic diseases.

The 4th MAC 2014 is being held under the patronage of the German Vascular Society (DGG) and the VASCULAR INTERNATIONAL foundation.

We look forward to welcoming you in Munich.

Hans-Henning Eckstein
Rüdiger Lange
Markus Schwaiger
Holger Poppert
Alma Zernecke
Wolfgang Wall
Michael Gee